慢性病中的乳化-线粒体轴:代谢重编程,表观遗传失调和治疗潜力
Yukun Gan1, Junming Zhang1, Xiushuo Fu1
1School of Medicine, Northwest University, Xi'an, 710069, Shaanxi, China.
Molecular and cellular biochemistry
|January 9, 2026
概括
慢性病 (CKD) 涉及纤维化和代谢功能障碍. 向脂肪酸氧化和乳酸代谢可能为病进展提供新的治疗策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 在病中代谢途径.
背景情况:
- 慢性病 (CKD) 是一个日益严重的全球健康问题,有效治疗方法有限.
- 脏间歇性纤维化,其特点是细胞外基质沉积过多,是CKD进展的关键病理过程.
- 代谢失调,包括脂肪酸氧化失调 (FAO) 和管状上皮细胞中乳酸代谢的改变,对损伤和纤维化有显著的贡献.
研究的目的:
- 突出维护脂肪酸氧化 (FAO) 对于正常功能的关键作用.
- 探索乳酸代谢在皮质中的重要性及其在病中的损害.
- 作为治疗策略,研究向乳糖化 (一种与炎症和脏病理中的代谢重编程相关的翻译后修饰) 的潜力.
主要方法:
- 对CKD中代谢现有文献的综述.
- 对脂肪酸氧化 (FAO) 在临近管状上皮细胞中的作用的分析.
- 检查乳酸代谢途径和乳酸化对病理学的影响.
主要成果:
- 破坏粮农组织和脂质新陈代谢障碍导致管间纤维化脏损伤.
- 管状上皮细胞中的乳酸代谢受损会导致乳酸积累,炎症和线粒体功能障碍.
- 乳化是一种新陈代谢重编程修改,在脏疾病中的炎症反应和线粒体功能障碍中起作用.
结论:
- 维持FAO对于保持正常功能至关重要.
- 改变乳酸代谢和随后的乳糖化是病病原发生的重要因素.
- 针对乳化过程的干预措施为病中新型治疗策略提供了有希望的途径.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
333
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
333
Chronic Kidney Disease I: Introduction
556
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
556
Chronic Kidney Disease II: Clinical Manifestations
543
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
543
Chronic Kidney Disease IV: Nursing Management
312
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
312
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Renal Regulation of Acid-Base Balance
1.5K
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
1.5K


